Information:
Error:
ID
16458
Description
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00153803
Link
https://clinicaltrials.gov/show/NCT00153803
Keywords
Versions (1)
- 7/17/16 7/17/16 -
Uploaded on
July 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00153803
Eligibility Carcinoma, Non-Small-Cell Lung NCT00153803
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00153803
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
NSCLC
Item
unresectable, stage iiia or iiib nsclc (measurable disease is not required)
boolean
C0007131 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,2])
metastatic disease
Item
no evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
Prior treatment
Item
no prior treatment
boolean
C1514463 (UMLS CUI [1])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Pulmonary function
Item
adequate pulmonary function (fev >= 1.0l or predicted fev >0.8l)
boolean
C0016529 (UMLS CUI [1])
Metastasis
Item
Metastasis
boolean
C0027627 (UMLS CUI [1])
Prior treatment
Item
prior treatment
boolean
C1514463 (UMLS CUI [1])
Malignant pleural or pericardial effusion
Item
malignant pleural or pericardial effusion
boolean
C0080032 (UMLS CUI [1])
C0220655 (UMLS CUI [2])
C0220655 (UMLS CUI [2])
Peripheral neuropathy
Item
peripheral neuropathy >= grade 2
boolean
C0031117 (UMLS CUI [1])